13,804 Shares in Astrana Health, Inc. (NASDAQ:ASTH) Bought by Stifel Financial Corp

Stifel Financial Corp acquired a new position in Astrana Health, Inc. (NASDAQ:ASTH) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 13,804 shares of the company’s stock, valued at approximately $800,000.

Several other large investors have also recently made changes to their positions in the business. GAMMA Investing LLC bought a new stake in shares of Astrana Health in the 3rd quarter worth approximately $34,000. Nisa Investment Advisors LLC purchased a new stake in Astrana Health in the third quarter worth $35,000. KBC Group NV bought a new stake in shares of Astrana Health in the third quarter valued at $70,000. Quarry LP purchased a new position in shares of Astrana Health during the 3rd quarter valued at $77,000. Finally, Quest Partners LLC bought a new position in shares of Astrana Health during the 3rd quarter worth $133,000. 52.77% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

ASTH has been the subject of a number of recent research reports. Robert W. Baird lifted their price objective on shares of Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a research note on Wednesday, November 13th. BTIG Research lifted their price target on Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a research report on Thursday, October 3rd. KeyCorp initiated coverage on Astrana Health in a report on Friday, October 11th. They set a “sector weight” rating on the stock. Macquarie upgraded Astrana Health to a “hold” rating in a research note on Monday, December 16th. Finally, TD Cowen assumed coverage on Astrana Health in a research report on Monday, October 14th. They set a “buy” rating and a $66.00 price target on the stock. Two research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Astrana Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $65.17.

Astrana Health Stock Performance

NASDAQ:ASTH opened at $33.48 on Wednesday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91. Astrana Health, Inc. has a fifty-two week low of $32.58 and a fifty-two week high of $63.20. The business has a 50 day moving average price of $46.70 and a 200-day moving average price of $47.86. The firm has a market cap of $1.88 billion, a PE ratio of 25.75, a price-to-earnings-growth ratio of 1.80 and a beta of 1.14.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings results on Thursday, November 7th. The company reported $0.33 earnings per share for the quarter, meeting the consensus estimate of $0.33. The business had revenue of $478.71 million for the quarter, compared to analysts’ expectations of $462.01 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. During the same quarter in the previous year, the business posted $0.47 earnings per share. Equities research analysts predict that Astrana Health, Inc. will post 1.16 earnings per share for the current year.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.